Handbook of Stem Cell Therapy 2022
DOI: 10.1007/978-981-19-2655-6_20
|View full text |Cite
|
Sign up to set email alerts
|

Augmenting Mesenchymal Stem Cell-Based Therapy of the Infarcted Myocardium with Statins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 127 publications
0
1
0
Order By: Relevance
“…Although using chemicals is considered a simple and preferred approach for MSC priming, approved drugs are advantageous because they are safe for human use and can be used for stem cell priming in clinics. Amongst the list of priming agents mentioned above, statins are gaining popularity[ 57 ]. Statins are a group of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors approved for cholesterol lowering.…”
Section: Pretreatment Approaches Of Mscsmentioning
confidence: 99%
“…Although using chemicals is considered a simple and preferred approach for MSC priming, approved drugs are advantageous because they are safe for human use and can be used for stem cell priming in clinics. Amongst the list of priming agents mentioned above, statins are gaining popularity[ 57 ]. Statins are a group of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors approved for cholesterol lowering.…”
Section: Pretreatment Approaches Of Mscsmentioning
confidence: 99%